Acute withdrawal from opioids




Download 1,5 Mb.
bet159/654
Sana03.01.2022
Hajmi1,5 Mb.
#14803
1   ...   155   156   157   158   159   160   161   162   ...   654
Acute withdrawal from opioids: There are insufficient data of the use of Dexmedetomidine for treatment of NAS so its use is not recommended for this indication. Clonidine may be preferred with its reduced sedative properties.

References

  1. van Hoorn CE, Hoeks SE, Essink H, Tibboel D, de Graaff JC. A systematic review and narrative synthesis on the histological and neurobehavioral long-term effects of dexmedetomidine. Paediatr Anaesth. 2019;29:125-36.

  2. Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine. Clinical Pharmacokinetics. 2017;56:893-913.

  3. Chrysostomou C, Schulman SR, Herrera Castellanos M, Cofer BE, Mitra S, da Rocha MG, Wisemandle WA, Gramlich L. A phase II/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates. J Pediatr. 2014;164:276-82.e1-3.

  4. Potts AL, Anderson BJ, Warman GR, Lerman J, Diaz SM, Vilo S. Dexmedetomidine pharmacokinetics in pediatric intensive care--a pooled analysis. Paediatr Anaesth. 2009;19:1119-29.

  5. Potts AL, Warman GR, Anderson BJ. Dexmedetomidine disposition in children: a population analysis. Paediatr Anaesth. 2008;18:722-30.

  6. Plambech MZ, Afshari A. Dexmedetomidine in the pediatric population: a review. Minerva Anestesiol. 2015;81:320-32.

  7. Chen K, Lu Z, Xin CY, Cai Y, Chen Y, Pan MS. Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients. Cochrane Database Syst Rev. 2019.

  8. Daverio M, Mondardini MC, Sperotto F, Coscini N, Amigoni A. Use of dexmedetomidine for prolonged sedation in pediatric patients: A systematic review. Pediatr Crit Care Med. 2018;19 (6 Supplement 1):196.

  9. Surkov D. Using of dexmedetomidine in term neonates with hypoxic-ischemic encephalopathy. Intensive Care Medicine Experimental Conference: 31st European Society of Intensive Care Medicine Annual Congress, ESICM. 2018;6.

  10. Chrysostomou C, Schulman S, Polak M, Herrera M, Cofer B, Gramlich L. A phase II/III, open-label, multicenter, safety, efficacy and pharmacokinetic study of dexmedetomidine in neonates ages >= 28 weeks to <= 44 weeks gestational age. Anesthesia and Analgesia. 2012;1):S392.

  11. O'Mara K, Gal P, Wimmer J, Ransom JL, Carlos RQ, Dimaguila MA, Davanzo CC, Smith M. Dexmedetomidine versus standard therapy with fentanyl for sedation in mechanically ventilated premature neonates. J Pediatr Pharmacol Ther. 2012;17:252-62.

  12. Bellon M, Le Bot A, Michelet D, Hilly J, Maesani M, Brasher C, Dahmani S. Efficacy of Intraoperative Dexmedetomidine Compared with Placebo for Postoperative Pain Management: A Meta-Analysis of Published Studies. Pain Ther. 2016;5:63-80.

  13. Schnabel A, Reichl SU, Poepping DM, Kranke P, Pogatzki-Zahn EM, Zahn PK. Efficacy and safety of intraoperative dexmedetomidine for acute postoperative pain in children: a meta-analysis of randomized controlled trials. Paediatr Anaesth. 2013;23:170-9.

  14. Wang W, Huang P, Gao W, Cao F, Yi M, Chen L, Guo X. Efficacy and Acceptability of Different Auxiliary Drugs in Pediatric Sevoflurane Anesthesia: A Network Meta-analysis of Mixed Treatment Comparisons. Sci. 2016;6:36553.

  15. Lam F, Bhutta AT, Tobias JD, Gossett JM, Morales L, Gupta P. Hemodynamic effects of dexmedetomidine in critically ill neonates and infants with heart disease. Pediatr Cardiol. 2012;33:1069-77.

  16. Ozcengiz D, Gunes Y, Atci M. Preliminary experience with dexmedetomidine in neonatal anaesthesia. J. 2011;27:17-22.

  17. Sellas MN, Kyllonen KC, Lepak MR, Rodriguez RJ. Dexmedetomidine for the Management of Postoperative Pain and Sedation in Newborns. J. 2019;24:227-33.

  18. Bong CL, Tan J, Lim S, Low Y, Sim SW, Rajadurai VS, Khoo PC, Allen J, Meaney M, Koh WP. Randomised controlled trial of dexmedetomidine sedation vs general anaesthesia for inguinal hernia surgery on perioperative outcomes in infants. Br J Anaesth. 2019;122:662-70.

  19. Oschman A, McCabe T, Kuhn RJ. Dexmedetomidine for opioid and benzodiazepine withdrawal in pediatric patients. Am J Health-Syst Pharm. 2011;68:1233-8.

  20. El Amrousy DM, Elshmaa NS, El-Kashlan M, Hassan S, Elsanosy M, Hablas N, Elrifaey S, El-Feky W. Efficacy of Prophylactic Dexmedetomidine in Preventing Postoperative Junctional Ectopic Tachycardia After Pediatric Cardiac Surgery. J Am Heart Assoc. 2017;6.

  21. Finkel JC, Quezado ZM. Hypothermia-induced bradycardia in a neonate receiving dexmedetomidine. J Clin Anesth. 2007;19:290-2.

  22. Kubota T, Fukasawa T, Kitamura E, Magota M, Kato Y, Natsume J, Okumura A. Epileptic seizures induced by dexmedetomidine in a neonate. Brain Dev. 2013;35:360-2.

  23. Whalen LD, Di Gennaro JL, Irby GA, Yanay O, Zimmerman JJ. Long-term dexmedetomidine use and safety profile among critically ill children and neonates. Pediatr Crit Care Med. 2014;15:706-14.

  24. Chrysostomou C, Komarlu R, Lichtenstein S, Shiderly D, Arora G, Orr R, Wearden PD, Morell VO, Munoz R, Jooste EH. Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease. Intensive Care Med. 2010;36:836-42.

  25. Chrysostomou C, Morell VO, Wearden P, Sanchez-de-Toledo J, Jooste EH, Beerman L. Dexmedetomidine: therapeutic use for the termination of reentrant supraventricular tachycardia. Congenit. 2013;8:48-56.

  26. Greenberg RG, Wu H, Laughon M, Capparelli E, Rowe S, Zimmerman KO, Smith PB, Cohen-Wolkowiez M. Population Pharmacokinetics of Dexmedetomidine in Infants. J Clin Pharmacol. 2017;57:1174-82.

  27. Su F, Gastonguay MR, Nicolson SC, DiLiberto M, Ocampo-Pelland A, Zuppa AF. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery. Anesth Analg. 2016;122:1556-66.

  28. Australian Injectable Drugs Handbook, 8th Edition, Society of Hospital Pharmacists of Australia. Accessed online 11th March 2020.

  29. Product Information. MIMS online. Accessed 11th March 2020.

  30. Micromedex online. Accessed 11th March 2020.



Original version Date: 28/5/2020

Author: NeoMed Consensus Group

Current Version number: 2

Current Version Date: 18/2/2021

Risk Rating: Medium

Due for Review: 18/2/2026

Approved by: DTC

Approval Date: TBA



Download 1,5 Mb.
1   ...   155   156   157   158   159   160   161   162   ...   654




Download 1,5 Mb.